AP NEWS

Market Trends Toward New Normal in Horizon Global, Bio-Techne, Adamis Pharmaceuticals, Kadant, Semgroup, and Provident Financial Services — Emerging Consolidated Expectations, Analyst Ratings

August 1, 2018

NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Horizon Global Corporation (NYSE:HZN), Bio-Techne Corp (NASDAQ:TECH), Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Kadant Inc (NYSE:KAI), Semgroup Corporation (NYSE:SEMG), and Provident Financial Services, Inc (NYSE:PFS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

HZN DOWNLOAD: http://Fundamental-Markets.com/register/?so=HZN TECH DOWNLOAD: http://Fundamental-Markets.com/register/?so=TECH ADMP DOWNLOAD: http://Fundamental-Markets.com/register/?so=ADMP KAI DOWNLOAD: http://Fundamental-Markets.com/register/?so=KAI SEMG DOWNLOAD: http://Fundamental-Markets.com/register/?so=SEMG PFS DOWNLOAD: http://Fundamental-Markets.com/register/?so=PFS

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Horizon Global Corporation (NYSE:HZN), Bio-Techne Corp (NASDAQ:TECH), Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Kadant Inc (NYSE:KAI), Semgroup Corporation (NYSE:SEMG), and Provident Financial Services, Inc (NYSE:PFS) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed July 30th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

HORIZON GLOBAL CORPORATION (HZN) REPORT OVERVIEW

Horizon Global’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Horizon Global reported revenue of $216.81MM vs $203.28MM (up 6.66%) and basic earnings per share -$2.30 vs -$0.41. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Horizon Global reported revenue of $892.98MM vs $649.20MM (up 37.55%) and basic earnings per share -$0.14 vs -$0.66. Horizon Global is expected to report earnings on August 7th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.84. The estimated EPS forecast for the next fiscal year is $0.47 and is expected to report on March 7th, 2019.

To read the full Horizon Global Corporation (HZN) report, download it here: http://Fundamental-Markets.com/register/?so=HZN

-----------------------------------------

BIO-TECHNE CORP (TECH) REPORT OVERVIEW

Bio-Techne’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Bio-Techne reported revenue of $163.97MM vs $144.04MM (up 13.84%) and basic earnings per share $0.53 vs $0.59 (down 10.17%). For the twelve months ended June 30th, 2017 vs June 30th, 2016, Bio-Techne reported revenue of $563.00MM vs $499.02MM (up 12.82%) and basic earnings per share $2.04 vs $2.81 (down 27.40%). Bio-Techne is expected to report earnings on August 7th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.02. The estimated EPS forecast for the next fiscal year is $4.54 and is expected to report on August 7th, 2018.

To read the full Bio-Techne Corp (TECH) report, download it here: http://Fundamental-Markets.com/register/?so=TECH

-----------------------------------------

ADAMIS PHARMACEUTICALS CORPORATION (ADMP) REPORT OVERVIEW

Adamis Pharmaceuticals’ Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Adamis Pharmaceuticals reported revenue of $3.18MM vs $3.04MM (up 4.65%) and basic earnings per share -$0.23 vs -$0.26. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Adamis Pharmaceuticals reported revenue of $13.07MM vs $6.47MM (up 101.94%) and basic earnings per share -$0.90 vs -$1.19. Adamis Pharmaceuticals is expected to report earnings on August 13th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.19. The estimated EPS forecast for the next fiscal year is -$0.34 and is expected to report on March 21st, 2019.

To read the full Adamis Pharmaceuticals Corporation (ADMP) report, download it here: http://Fundamental-Markets.com/register/?so=ADMP

-----------------------------------------

KADANT INC (KAI) REPORT OVERVIEW

Kadant’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Kadant reported revenue of $149.19MM vs $102.86MM (up 45.05%) and basic earnings per share $0.98 vs $0.82 (up 19.51%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Kadant reported revenue of $515.03MM vs $414.13MM (up 24.37%) and basic earnings per share $2.83 vs $2.95 (down 4.07%). Kadant is expected to report earnings on October 29th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $1.49. The estimated EPS forecast for the next fiscal year is $5.88 and is expected to report on February 21st, 2019.

To read the full Kadant Inc (KAI) report, download it here: http://Fundamental-Markets.com/register/?so=KAI

-----------------------------------------

SEMGROUP CORPORATION (SEMG) REPORT OVERVIEW

Semgroup’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Semgroup reported revenue of $661.61MM vs $456.10MM (up 45.06%) and basic earnings per share -$0.48 vs -$0.16. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Semgroup reported revenue of $2,081.92MM vs $1,332.16MM (up 56.28%) and basic earnings per share -$0.24 vs $0.04. Semgroup is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.15. The estimated EPS forecast for the next fiscal year is $0.93 and is expected to report on February 25th, 2019.

To read the full Semgroup Corporation (SEMG) report, download it here: http://Fundamental-Markets.com/register/?so=SEMG

-----------------------------------------

PROVIDENT FINANCIAL SERVICES, INC (PFS) REPORT OVERVIEW

Provident Financial Services’ Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Provident Financial Services reported interest income of $86.33MM vs $77.91MM (up 10.80%) and basic earnings per share $0.43 vs $0.37 (up 16.22%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Provident Financial Services reported interest income of $323.85MM vs $302.32MM (up 7.12%) and basic earnings per share $1.46 vs $1.38 (up 5.80%). Provident Financial Services is expected to report earnings on October 26th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.41. The estimated EPS forecast for the next fiscal year is $1.81 and is expected to report on January 25th, 2019.

To read the full Provident Financial Services, Inc (PFS) report, download it here: http://Fundamental-Markets.com/register/?so=PFS

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

AP RADIO
Update hourly